UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Sheets Smith Wealth Management

Sheets Smith Wealth Management decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,014 shares of the healthcare conglomerate’s stock after selling 30 shares during the period. Sheets Smith Wealth Management’s holdings in UnitedHealth Group were worth $2,640,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in UNH. Bray Capital Advisors boosted its position in shares of UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after purchasing an additional 50 shares during the period. Defined Wealth Management LLC boosted its position in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Defined Wealth Management LLC now owns 3,406 shares of the healthcare conglomerate’s stock worth $1,717,000 after purchasing an additional 28 shares during the period. Tcwp LLC boosted its position in shares of UnitedHealth Group by 0.6% during the 3rd quarter. Tcwp LLC now owns 5,481 shares of the healthcare conglomerate’s stock worth $2,763,000 after purchasing an additional 33 shares during the period. J.W. Cole Advisors Inc. boosted its position in UnitedHealth Group by 4.5% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 4,708 shares of the healthcare conglomerate’s stock valued at $2,374,000 after buying an additional 201 shares during the period. Finally, Channel Wealth LLC boosted its position in UnitedHealth Group by 13.7% in the 3rd quarter. Channel Wealth LLC now owns 6,424 shares of the healthcare conglomerate’s stock valued at $3,239,000 after buying an additional 775 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

NYSE UNH traded down $0.52 during trading on Friday, reaching $492.45. The company’s stock had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The firm has a market cap of $453.09 billion, a price-to-earnings ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The business’s fifty day moving average price is $482.32 and its 200-day moving average price is $512.42.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.26 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Wall Street Analyst Weigh In

UNH has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Barclays raised their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Truist Financial restated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Piper Sandler raised their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Finally, HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.